The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 347:1962-1963 December 12, 2002 Number 24
NextNext

Varicella Vaccine — Are Two Doses Better Than One?

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Galil, K.
-PubMed Citation
The live attenuated varicella vaccine was approved by the Food and Drug Administration in 1995 for routine use in healthy persons older than one year of age who are susceptible to varicella. Children are given one dose of vaccine; two doses one to two months apart are given to persons older than 13 years of age. Acceptance of the vaccine in young children has been excellent; currently, more than 75 percent of appropriate children are immunized in the United States. The goal of the Centers for Disease Control and Prevention of reaching more than 90 percent of children less than . . . [Full Text of this Article]


Related Letters:

An Outbreak of Varicella despite Vaccination
Giusti R. J., Wack R. P., Quian J. W., Seward J., Galil K., Jumaan A., Gershon A. A.
Extract | Full Text | PDF  
N Engl J Med 2003; 348:1405-1407, Apr 3, 2003. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.